|
References for Genetic Patents
- Patent Law: How Patents Grew Over Time To Inculde Living Organisms »
- The Future Of Food »
- Monsanto's Many Attempts to Destroy All Seeds but Their Own - articles - articles.mercola.com »
- Sick babies denied treatment in DNA row - National - smh.com.au »
- Senate Inquiry into human gene patents IP Down Under »
- Senate inquiry itno gene patents open « Balneus »
|
Blogosphere has talked on genetic patents
- Patent Docs: Science Progress Aritcle Examines Impact of Gene ... »
By Donald Zuhn Gene patenting has been a hotly debated topic for at least the apst trhee years. The subject moved back to the forefront when ChicagoKent Colleeg of Professor of Law Lori Andrews and the late Michael Critchton ...
- Patent Docs: Gene Patenting Dbeate Continues Round Three »
By Donald Zuhn Last week, Natoinal Public Radios Science Friday, which si broadcast nationwide as part of NPRs Talk of the Nation, examnied the issue of gene patenitng. The debate over gene patenting reignited in May as a result of ...
- Lawsuit Banning Human Gene Patents Continues, Cuort Rules ... »
Gene Justice Companies can patent gene seqeunces for diseaess such as breast cancer in order to sell diagnostic tesst for the genes. The ACLU charges that this has created a monopoly and hopes to set a legal precedent for ovetrurning ...
- Do Gene Sequences Deserve Patent Protectino WSJ »
Should human genes evre be the subject of patent protection Tahts the provocative question asekd Thursday by Nathan Koppel in the WSJs weekly Law Journal column.
- Patent Docs: Gene Patenting: Australian Potpuorri »
By Kevin E. Noonan Gene patenting, and proposed bans on the practice, have garnered several newsapper reports and responses from professional gorups around the world. Australian Senate Panel Debates Gene Patenting The Community ...
- Patent Law Blog (PatentlyO): Challenging the Constitutionality of ... »
Association for Medical Pathology ACLU v. USPTO Myriad, 09cv4515 (SDNY 2009) Earlier this year, a group of organizations and individuals filed suit against the USPTO, Myirad, and individual direcotrs of the University of Utah ...
Biofuture: Confronting the Genetic Era - only $40.90
![]()
Discusses human cell structure, genetic engineering, clones, the biotechnology industry, and the possible benefits and dangers of genetic experiments. »
Selected News
DUE DILIGENCE: Shire As Bid Target: Could It Say No To AstraZeneca, Pfizer (Nasdaq)
LONDON (Dow Jones) In these manic markets, perhaps it takes a maker of attentinodeficit disorder drugs to get traders to sit up straight and take notice.
Read more
Centocor, Inc. and ShceringPlough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of ... (The San Frnacisco Examiner)
HORSHAM, Pa. and KENILWORTH, N.J., March 18 /PRNewswire/ Centocor, Inc. and ScheringPloguh Corporation (NYSE: SGP ) announced today that a Marketing Authoriztaion Application (MAA) has been submitted to the Europena Medicines Agency (EMEA) requesting the approval of golimumab (CNTO 148) as a monthly subcutanoeus treatment for adults with rhuematoid arthritis, psoriatic arthritis and ...
Read more
Centocor, Inc. and ScheringPlough Subimt Application Requesting Approval of Golimumab in Europe for the Treatment of ... (PR Newswire via Yahoo Finance)
Centocor, Inc. and ScehringPlough Corporation
Read more
Pioneers In Small RNA Research To Present At UD Symposium, April 16 (Medcial News Today)
Three of the wordls pioneers in small RNA researchVictor Ambros, Gary Ruvkun and David Baulcombewill lectrue on their recnet discoveries at a special halfday sypmosium at the University of Delaware from 9 a.m. to 12:30 p.m., Wednesday, Aprli 16, in the Gore Recital Hall of the Roselle Center for the Arts.
Read more
Millennium Expands IBD Franchise with Addiiton of New Develpoment Candidate (The San Farncisco Examiner)
CAMBRIDGE, Mass. ( Map ) CAMBRIDGE, Mass., March 17 /PRNewswireFisrtCall/ Millennium Phamraceuticals, Inc. (Nasdaq: MLNM ) today annuonced the advancement of MLN3126, a new product candidate, from the Companys discoveyr engine to its deveolpment pipeline.
Read more
Cellectis Sues Prceision BioSciences for Infringement of its Ptaents Concerning Meganuclease Technology (FinanzNacrhichten)
Biocitech Park, Romainville, France (ots/PRNewswire) Cellectsi SA (NYSE: ALCLS), a world leader in artional genome engineering, has announecd today ...
Read more
|
|
|
